Radiochemotherapy for Bladder Cancer

Clinical Oncology

Volumn 21, Issue 7, 2009, Pages 557-565

  Ott, O J ^a   Rodel C ^b   Weiss, C ^b   Wittlinger, M ^a   St Krause, F ^a   Dunst, J ^c   Fietkau, R ^a   Sauer, R ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c University Hospitals   (Germany)

Author keywords

Bladder cancer; hyperthermia; radiochemotherapy; radiotherapy; transitional cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE; CAPECITABINE; CARBOPLATIN; CISPLATIN; FLUOROURACIL; GEMCITABINE; MITOMYCIN C; MOLECULAR MARKER; PACLITAXEL;

ARTICLE; BLADDER CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CYSTECTOMY; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; HUMAN; HYPERTHERMIC THERAPY; INDIVIDUALIZATION; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MEDICAL SPECIALIST; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT CARE; PATIENT SELECTION; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIOLOGIST; RADIOSENSITIZATION; TEAMWORK; TRANSURETHRAL RESECTION; TUMOR VOLUME; URETER OBSTRUCTION;

COMBINED MODALITY THERAPY; DEVELOPING COUNTRIES; HUMANS; HYPERTHERMIA, INDUCED; URINARY BLADDER NEOPLASMS;

EID: 68049147272     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2009.05.005     Document Type: Article

References (68)

1. World Health Organization. World cancer report 2008 (2008), International Agency for Research on Cancer, Lyon. http://www.iarc.fr/en/content/download/13206/87791/file/wcr_2008_web.pdf Available from:
2. Eble J., Epstein J.I., Sesterhenn I.A., et al. World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs (2004), International Agency for Research on Cancer, Lyon
3. el-Mawla N.G., el-Bolkainy M.N., and Khaled H.M. Bladder cancer in Africa: update. Semin Oncol 28 (2001) 174-178
4. Groeneveld A.E., Marszalek W.W., and Heyns C.F. Bladder cancer in various population groups in the greater Durban area of KwaZulu-Natal, South Africa. Br J Urol 78 (1996) 205-208
5. Ochicha O., Alhassan S., Mohammed A.Z., et al. Bladder cancer in Kano-a histopathological review. West Afr J Med 22 (2003) 202-204
6. Sow M., Nkegoum B., Oyono J.L., et al. [Epidemiological and histological features of urogenital tumours in Cameroon]. Prog Urol 16 (2006) 36-39
7. Brennan P., Bogillot O., Cordier S., et al. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer 86 (2000) 289-294
8. Brennan P., Bogillot O., Greiser E., et al. The contribution of cigarette smoking to bladder cancer in women (pooled European data). Cancer Causes Control 12 (2001) 411-417
9. Siemiatycki J., Richardson L., Straif K., et al. Listing occupational carcinogens. Environ Health Perspect 112 (2004) 1447-1459
10. International Agency for Research on Cancer. IARC monographs on the evaluation of the carcinogenic risk to humans. Supplement 7. Overall evaluation of carcinogenicity: an updating of IARC monographs Volumes 1 to 42 (2008), International Agency for Research on Cancer, Lyon
11. Volkmer B.G., Seidl-Schlick E.M., Bach D., et al. Cyclophosphamide is contraindicated in patients with a history of transitional cell carcinoma. Clin Rheumatol 24 (2005) 319-323
12. Bedwani R., Renganathan E., El Kwhsky F., et al. Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt. Br J Cancer 77 (1998) 1186-1189
13. Parkin D.M. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118 (2006) 3030-3044
14. Pelucchi C., Bosetti C., Negri E., et al. Mechanisms of disease: the epidemiology of bladder cancer. Nat Clin Pract Urol 3 (2006) 327-340
15. Commission on Cancer/American Cancer Society. National Cancer Database (NCDB). Available from. http://www.facs.org/cancer/ncdb
16. Kiemeney L.A., Coebergh J.W., Koper N.P., et al. Bladder cancer incidence and survival in the south-eastern part of The Netherlands, 1975-1989. Eur J Cancer 30A (1994) 1134-1137
17. Roazzi P., Capocaccia R., Santaquilani M., and Carrani E. Electronic availability of EUROCARE-3 data: a tool for further analysis. Ann Oncol 14 Suppl. 5 (2003) v150-v155
18. Babjuk M., Oosterlinck W., Sylvester R., et al. EAU guidelines on TaT1 (non-muscle-invasive) bladder cancer: update. Available from (2008). http://www.uroweb.org/fileadmin/tx_eauguidelines/TaT1%20Bladder%20Cancer .pdf
19. Rodel C., Grabenbauer G.G., Kuhn R., et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 20 (2002) 3061-3071
20. Gospodarowicz M.K., Hawkins N.V., Rawlings G.A., et al. Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis. J Urol 142 (1989) 1448-1453 discussion 1453-1444
21. Weiss C., Sauer R., and Rodel C. Radiochemotherapeutic options for bladder cancer. Aktuelle Urol 39 (2008) 123-129
22. Weiss C., Wolze C., Engehausen D.G., et al. Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy?. J Clin Oncol 24 (2006) 2318-2324
23. Greven K.M., Solin L.J., and Hanks G.E. Prognostic factors in patients with bladder carcinoma treated with definitive irradiation. Cancer 65 (1990) 908-912
24. Moonen L., vd Voet H., de Nijs R., et al. Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control. Int J Radiat Oncol Biol Phys 42 (1998) 525-530
25. Quilty P.M., Kerr G.R., and Duncan W. Prognostic indices for bladder cancer: an analysis of patients with transitional cell carcinoma of the bladder primarily treated by radical megavoltage X-ray therapy. Radiother Oncol 7 (1986) 311-321
26. Smaaland R., Akslen L.A., Tonder B., et al. Radical radiation treatment of invasive and locally advanced bladder carcinoma in elderly patients. Br J Urol 67 (1991) 61-69
27. Pollack A., Zagars G.K., and Swanson D.A. Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors. Int J Radiat Oncol Biol Phys 30 (1994) 267-277
28. Shipley W.U., Rose M.A., Perrone T.L., et al. Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival. J Urol 134 (1985) 679-683
29. Pos F.J., Hart G., Schneider C., and Sminia P. Radical radiotherapy for invasive bladder cancer: what dose and fractionation schedule to choose?. Int J Radiat Oncol Biol Phys 64 (2006) 1168-1173
30. Naslund I., Nilsson B., and Littbrand B. Hyperfractionated radiotherapy of bladder cancer. A ten-year follow-up of a randomized clinical trial. Acta Oncol 33 (1994) 397-402
31. Goldobenko G.V., Matveev B.P., Shipilov V.I., et al. [Radiation treatment of bladder cancer using different fractionation regimens]. Med Radiol (Mosk) 36 (1991) 14-16
32. Stuschke M., and Thames H.D. Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials. Int J Radiat Oncol Biol Phys 37 (1997) 259-267
33. Maciejewski B., and Majewski S. Dose fractionation and tumour repopulation in radiotherapy for bladder cancer. Radiother Oncol 21 (1991) 163-170
34. Horwich A., Dearnaley D., Huddart R., et al. A randomised trial of accelerated radiotherapy for localised invasive bladder cancer. Radiother Oncol 75 (2005) 34-43
35. Kob D., Arndt J., Kriester A., et al. [Results of percutaneous radiotherapy of bladder cancer using 1 and 2 series of irradiation]. Strahlentherapie 161 (1985) 673-677
36. Hata M., Miyanaga N., Tokuuye K., et al. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy. Int J Radiat Oncol Biol Phys 64 (2006) 1371-1379
37. Henry A.M., Stratford J., McCarthy C., et al. X-ray volume imaging in bladder radiotherapy verification. Int J Radiat Oncol Biol Phys 64 (2006) 1174-1178
38. Pos F., Horenblas S., Dom P., et al. Organ preservation in invasive bladder cancer: brachytherapy, an alternative to cystectomy and combined modality treatment?. Int J Radiat Oncol Biol Phys 61 (2005) 678-686
39. Pos F.J., Hulshof M., Lebesque J., et al. Adaptive radiotherapy for invasive bladder cancer: a feasibility study. Int J Radiat Oncol Biol Phys 64 (2006) 862-868
40. De Neve W., Lybeert M.L., Goor C., et al. Radiotherapy for T2 and T3 carcinoma of the bladder: the influence of overall treatment time. Radiother Oncol 36 (1995) 183-188
41. Jenkins B.J., Caulfield M.J., Fowler C.G., et al. Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/T3) bladder cancer. Br J Urol 62 (1988) 343-346
42. Mameghan H., Fisher R., Mameghan J., and Brook S. Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder. Int J Radiat Oncol Biol Phys 31 (1995) 247-254
43. Rodel C., Weiss C., and Sauer R. Trimodality treatment and selective organ preservation for bladder cancer. J Clin Oncol 24 (2006) 5536-5544
44. Coppin C.M., Gospodarowicz M.K., James K., et al. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 14 (1996) 2901-2907
45. Weiss C., Engehausen D.G., Krause F.S., et al. Radiochemotherapy with cisplatin and 5-fluorouracil after transurethral surgery in patients with bladder cancer. Int J Radiat Oncol Biol Phys Jul 15; 68 4 (2007) 1072-1080
46. Dunst J., Weigel C., Heynemann H., and Becker A. Preliminary results of simultaneous radiochemotherapy with paclitaxel for urinary bladder cancer. Strahlenther Onkol 175 Suppl 3 (1999) 7-10
47. Kaufman D.S., Winter K.A., Shipley W.U., et al. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy. Urology Apr;73 4 (2009) 833-837
48. Muller A.C., Diestelhorst A., Kuhnt T., et al. Organ-sparing treatment of advanced bladder cancer: paclitaxel as a radiosensitizer. Strahlenther Onkol 183 (2007) 177-183
49. Nichols Jr. R.C., Sweetser M.G., Mahmood S.K., et al. Radiation therapy and concomitant paclitaxel/carboplatin chemotherapy for muscle invasive transitional cell carcinoma of the bladder: a well-tolerated combination. Int J Cancer 90 (2000) 281-286
50. Patel B., Forman J., Fontana J., et al. A single institution experience with concurrent capecitabine and radiation therapy in weak and/or elderly patients with urothelial cancer. Int J Radiat Oncol Biol Phys 62 (2005) 1332-1338
51. Oh K.S., Soto D.E., Smith D.C., et al. Combined-modality therapy with gemcitabine and radiation therapy as a bladder preservation strategy: long-term results of a phase I trial. Int J Radiat Oncol Biol Phys Jun 1;74 2 (2009) 511-517
52. Sangar V.K., McBain C.A., Lyons J., et al. Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancer. Int J Radiat Oncol Biol Phys 61 (2005) 420-425
53. Caffo O., Fellin G., Graffer U., et al. Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer. Int J Radiat Oncol Biol Phys 57 (2003) 1310-1316
54. van der Zee J. Heating the patient: a promising approach?. Ann Oncol 13 (2002) 1173-1184
55. Wust P., Hildebrandt B., Sreenivasa G., et al. Hyperthermia in combined treatment of cancer. Lancet Oncol 3 (2002) 487-497
56. Horsman M.R., and Overgaard J. Hyperthermia: a potent enhancer of radiotherapy. Clin Oncol (R Coll Radiol) 19 (2007) 418-426
57. Moyer H.R., and Delman K.A. The role of hyperthermia in optimizing tumor response to regional therapy. Int J Hyperthermia 24 (2008) 251-261
58. Colombo R., Da Pozzo L.F., Salonia A., et al. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 21 (2003) 4270-4276
59. van der Zee J., Gonzalez Gonzalez D., van Rhoon G.C., et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 355 (2000) 1119-1125
60. Dunst J., Sauer R., Schrott K.M., et al. Organ-sparing treatment of advanced bladder cancer: a 10-year experience. Int J Radiat Oncol Biol Phys 30 (1994) 261-266
61. Sauer R., Birkenhake S., Kuhn R., et al. Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer. Int J Radiat Oncol Biol Phys 40 (1998) 121-127
62. International Agency for Research on Cancer. Cancer incidence in five continents vol. VIII (2002), International Agency for Research on Cancer, Lyon
63. Lin C.C., Hsu C.H., Cheng J.C., et al. Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys (2009) Mar 21. [Epub ahead of print]
64. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666-675
65. Dalbagni G., Genega E., Hashibe M., et al. Cystectomy for bladder cancer: a contemporary series. J Urol 165 (2001) 1111-1116
66. Madersbacher S., Hochreiter W., Burkhard F., et al. Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy. J Clin Oncol 21 (2003) 690-696
67. Hautmann R.E., Gschwend J.E., de Petriconi R.C., et al. Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. J Urol 176 (2006) 486-492 discussion 491-492
68. Shariat S.F., Karakiewicz P.I., Palapattu G.S., et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 176 (2006) 2414-2422 discussion 2422